- IN₹36.17bn
- IN₹41.70bn
- IN₹25.65bn
Brief: Aarti Drugs Incorporates "Pinnacle Life Science LLC"
Brief: Aarti Drugs Says Co Has Incorporated Marketing Subsidiary Namely 'Pinnacle Chile SpA' In Chile
Brief: Aarti Drugs To Expand In Antiinflammatory Therapeutic Category This FY
Brief: India's Aarti Drugs Reports Rise In Sept Qtr Consol Profit
Brief: India's Aarti Drugs June Quarter Consol Net Profit Falls
Brief: India's Aarti Drugs Dec Qtr Consol Profit Falls
Brief: India's Aarti Drugs Sept-Qtr Consol Profit Falls
Brief: India's Aarti Drugs June-Qtr Consol Profit More Than Doubles
Brief: India's Aarti Drugs March-Qtr Consol Profit Rises
Brief: Aarti Drugs Updates On Damages Caused By Explosion In Adjoining Unit Of Novaphene Specialties
Brief: Aarti Drugs Says Unit Affected Due To Explosion In Adjoining Unit In Tarapur
Brief: India's Aarti Drugs Dec-Qtr Consol Profit Rises
Brief: India's Aarti Drugs Approves Buyback Of Equity Shares
Brief: Aarti Drugs To Consider Proposal Of Buyback Of Fully Paid-Up Equity Shares Of Co
Brief: India's Aarti Drugs Sept-qtr profit falls
Brief: India's Aarti Drugs June-qtr profit falls
Brief: Aarti Drugs gets closure directions for Tarapur unit
Brief: Aarti Drugs Dec-qtr consol profit rises
Brief: Aarti Drugs approves buyback of shares worth 270 million rupees